Home › Funds › Harvest Portfolios Group Inc. › VRTX

Harvest Portfolios Group Inc. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

Harvest Portfolios Group Inc. reported holding 150,045 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$78.4M, representing 0.99% of its reported portfolio and ranking #29 among its reported holdings. Harvest Portfolios Group Inc. has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)150.04K sh
Reported value held$78.45M
Portfolio Weight0.99%
First reportedQ2 2026
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Harvest Portfolios Group Inc.'s VRTX position evolved

Harvest Portfolios Group Inc. first disclosed a stake in VRTX in Q2 2026 at 148,195 shares (US$73.6M). The position peaked in Q3 2026 at 150,045 shares, worth US$78.4M. Across 2 filings, Harvest Portfolios Group Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 150,045 shares valued at US$78.4M — an increase of 1,850 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 148.19K $73.61M New
Q3 2026 150.04K $78.45M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has Harvest Portfolios Group Inc. held VRTX?

Harvest Portfolios Group Inc. has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Harvest Portfolios Group Inc.'s current position in VRTX?

As of Q3 2026, Harvest Portfolios Group Inc. holds 150.04K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $78.45M, representing 0.99% of its reported portfolio and ranking #29.

Has Harvest Portfolios Group Inc. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), Harvest Portfolios Group Inc. increased its position in VRTX. The position peaked in Q3 2026 at 150.04K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.